Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Agnosia × Dexmedetomidine × Clear all

Phase

Phase NA 4 Phase 2/3 2 Phase 4 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Pain, Postoperative 3 Neoplasms 2 Agnosia 2 Thyroid Neoplasms 1 Postoperative Analgesia 1 Pain, Intractable 1 Neoplasm Metastasis 1 Inflammation 1

Interventions

Ketamine 2 Dexmedetomidine 2 Bupivacaine 2 Oxycodone 1 Morphine 1 Lidocaine 1 Ketorolac 1 Diazepam 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02455609 2015-05-28

Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

Assiut University

Phase 2/3 Unknown

Agnosia, Pain, Postoperative

NCT02435537 2015-05-06

ITMandDEX

Assiut University

Phase 2/3 Completed

Agnosia, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡